Formulary Search
Search Results : Primary insomnia (Loprazolam mesilate - Primary insomnia)
Show Icon and Status Keys
- Tablets
Short term treatment of sleep disturbances (max of 2 to 4 weeks), considered severe or disabling or where insomnia is subjecting the individual to extreme distress.
- Oral suspension
Short term treatment of sleep disturbances (max of 2 to 4 weeks), considered severe or disabling or where insomnia is subjecting the individual to extreme distress.
Liquid formulations are expensive and should only be used where significant swallowing difficulties or feeding tube
- Tablets
Short term treatment of sleep disturbances (max of 2 to 4 weeks), considered severe or disabling or where insomnia is subjecting the individual to extreme distress.
- Oral solution
Short term treatment of sleep disturbances (max of 2 to 4 weeks), considered severe or disabling or where insomnia is subjecting the individual to extreme distress.
Liquid formulations are expensive and should only be used where significant swallowing difficulties or feeding tube
- Tablets
For the short-term treatment of insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.
- Oro-dispersible tablets
Orodispersible tablets have not been agreed for addition to formulary. Please contact pharmacy for advice.
- Tablets
For the short-term treatment of insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.
- Not Specified
Not prescribable on the NHS in Primary Care.